LARVAL DEBRIDEMENT THERAPY PRODUCTS - BIOBAG 50/100/200/300/400— 510(k) K131221

Name: FDA 510(k) clearance K131221
Creator: U.S. Food and Drug Administration
Published: 2013-08-28

Substantially Equivalent

Biomonde

FDA 510(k) clearance K131221 for LARVAL DEBRIDEMENT THERAPY PRODUCTS - BIOBAG 50/100/200/300/400, Substantially Equivalent on 2013-08-28. Applicant: Biomonde. Device class: Unclassified.

Clearance details

Applicant: Biomonde
Product code: Code NQK
Device class: Unclassified
Advisory panel: Unknown
Date received: 2013-04-30
Decision date: 2013-08-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Marlborough, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code NQK

view all

K142020 — LARVAL DEBRIDEMENT THERAPY PRODUCTS - LARVAE 100/200/300 AND BIOBAG 50/100/200/300/4002014-11-05
K123449 — BIOMONDE LARVAE2013-03-05
K102827 — MEDICAL MAGGOTS, LESOC2011-11-02
K072438 — MEDICAL MAGGOTS, CREATURE COMFORTS2007-10-05
K033391 — MEDICAL MAGGOTS2004-01-12

Data sourced from openFDA. This site is unofficial and independent of the FDA.